Osteoporosis and aromatase inhibitors: experience and future prospects
Osteoporosis and aromatase inhibitors: experience and future prospects In general, aromatase inhibitors are only used to treat breast cancer in postmenopausal women. Hormone therapy is recommended for a full five to 10 years after the primary treatment of breast cancer, so the cost of tamoxifen or your aromatase inhibitor is an important factor to consider.